These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 9890172)

  • 1. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group.
    J Natl Cancer Inst; 1999 Jan; 91(1):66-72. PubMed ID: 9890172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vinorelbine: a review of its use in elderly patients with advanced non-small cell lung cancer.
    Curran MP; Plosker GL
    Drugs Aging; 2002; 19(9):695-721. PubMed ID: 12381238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ELVIS trial: a phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study.
    Gridelli C
    Oncologist; 2001; 6 Suppl 1():4-7. PubMed ID: 11181997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study.
    Gridelli C; Perrone F; Gallo C; De Marinis F; Ianniello G; Cigolari S; Cariello S; Di Costanzo F; D'Aprile M; Rossi A; Migliorino R; Bartolucci R; Bianco AR; Pergola M; Monfardini S
    Eur J Cancer; 1997 Mar; 33(3):392-7. PubMed ID: 9155522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.
    Westeel V; Quoix E; Moro-Sibilot D; Mercier M; Breton JL; Debieuvre D; Richard P; Haller MA; Milleron B; Herman D; Level MC; Lebas FX; Puyraveau M; Depierre A;
    J Natl Cancer Inst; 2005 Apr; 97(7):499-506. PubMed ID: 15812075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.
    Gridelli C; Perrone F; Gallo C; Cigolari S; Rossi A; Piantedosi F; Barbera S; Ferraù F; Piazza E; Rosetti F; Clerici M; Bertetto O; Robbiati SF; Frontini L; Sacco C; Castiglione F; Favaretto A; Novello S; Migliorino MR; Gasparini G; Galetta D; Iaffaioli RV; Gebbia V;
    J Natl Cancer Inst; 2003 Mar; 95(5):362-72. PubMed ID: 12618501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer.
    Crawford J; O'Rourke M; Schiller JH; Spiridonidis CH; Yanovich S; Ozer H; Langleben A; Hutchins L; Koletsky A; Clamon G; Burman S; White R; Hohneker J
    J Clin Oncol; 1996 Oct; 14(10):2774-84. PubMed ID: 8874339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
    Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
    Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer.
    von Plessen C; Bergman B; Andresen O; Bremnes RM; Sundstrom S; Gilleryd M; Stephens R; Vilsvik J; Aasebo U; Sorenson S
    Br J Cancer; 2006 Oct; 95(8):966-73. PubMed ID: 17047644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer.
    Frasci G; Lorusso V; Panza N; Comella P; Nicolella G; Bianco A; De Cataldis G; Iannelli A; Bilancia D; Belli M; Massidda B; Piantedosi F; Comella G; De Lena M
    J Clin Oncol; 2000 Jul; 18(13):2529-36. PubMed ID: 10893283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904).
    Kudoh S; Takeda K; Nakagawa K; Takada M; Katakami N; Matsui K; Shinkai T; Sawa T; Goto I; Semba H; Seto T; Ando M; Satoh T; Yoshimura N; Negoro S; Fukuoka M
    J Clin Oncol; 2006 Aug; 24(22):3657-63. PubMed ID: 16877734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
    Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vinorelbine in elderly patients with inoperable nonsmall cell lung carcinoma: a phase II study.
    Buccheri G; Ferrigno D
    Cancer; 2000 Jun; 88(12):2677-85. PubMed ID: 10870049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of advanced non-small cell lung cancer with vinorelbine in elderly Thai patients.
    Sorraritchingchai S; Thongprasert S; Charoentum C; Chewasakulyong B; Moonprakan S
    J Med Assoc Thai; 2004 Apr; 87(4):367-71. PubMed ID: 15217171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
    Gebbia V; Lorusso V; Galetta D; Caruso M M; Palomba G; Riccardi F; Borsellino N; Carrozza F; Leo S; Ferraù F; Cinieri S; Mancuso G; Mancarella S; Colucci G
    Lung Cancer; 2010 Aug; 69(2):218-24. PubMed ID: 19910076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial.
    Frasci G; Lorusso V; Panza N; Comella P; Nicolella G; Bianco A; DeCataldis G; Belli M; Iannelli N; Massidda B; Mascia V; Comella G; De Lena M
    Lung Cancer; 2001 Dec; 34 Suppl 4():S65-9. PubMed ID: 11742706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update: vinorelbine (navelbine) in non-small cell lung cancer.
    Crawford J
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):2-7. PubMed ID: 8610232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-agent vinorelbine in the treatment of non-small cell lung cancer.
    Wozniak AJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):62-6; discussion 71-2. PubMed ID: 10585010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of single-agent oral vinorelbine in elderly (> or =70 years) patients with advanced non-small-cell lung cancer and poor performance status.
    Camerini A; Valsuani C; Mazzoni F; Siclari O; Puccetti C; Donati S; Rondini M; Tartarelli G; Puccinelli P; Di Costanzo F; Amoroso D
    Ann Oncol; 2010 Jun; 21(6):1290-1295. PubMed ID: 19914959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10.
    Pepe C; Hasan B; Winton TL; Seymour L; Graham B; Livingston RB; Johnson DH; Rigas JR; Ding K; Shepherd FA;
    J Clin Oncol; 2007 Apr; 25(12):1553-61. PubMed ID: 17442999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.